Evidence map›Paper›PMID 34956129›Full record

ArticleFrontiers in microbiology2021

Zinc Oxide Nanoparticles Prime a Protective Immune Response in

Mei-Nian Xu, Li Li, Wen Pan, Huan-Xin Zheng, Meng-Lei Wang, Xiao-Ming Peng, Si-Qi Dai, Ying-Mei Tang, Kang Zeng, Xiao-Wen Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Journal of fungi (Basel, Switzerland) · 2025
    Review
  9. Nanomaterials (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antibacterial Activity of ZnO Nanoparticles in aJournal of functional biomaterials · 2023
    Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Mei-Nian XuDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Li LiDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wen PanDivision of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, United States.
Huan-Xin ZhengDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Meng-Lei WangDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xiao-Ming PengDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Si-Qi DaiDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ying-Mei TangDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Kang ZengDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xiao-Wen HuangDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Nanfang Hospital · CNSouthern Medical University · CNRhode Island Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-infectionCandia albicansGalleria mellonellainnate immunityzinc oxide nanoparticles

Identifiers

PMID34956129
PMCPMC8702860
OpenAlexW4200474156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.